GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (NSE:SOLARAPP) » Definitions » PB Ratio

Solara Active Pharma Sciences (NSE:SOLARAPP) PB Ratio : 1.10 (As of Apr. 01, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Solara Active Pharma Sciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-01), Solara Active Pharma Sciences's share price is ₹249.20. Solara Active Pharma Sciences's Book Value per Share for the quarter that ended in Dec. 2024 was ₹226.24. Hence, Solara Active Pharma Sciences's PB Ratio of today is 1.10.

The historical rank and industry rank for Solara Active Pharma Sciences's PB Ratio or its related term are showing as below:

NSE:SOLARAPP' s PB Ratio Range Over the Past 10 Years
Min: 0.76   Med: 1.17   Max: 4
Current: 2.26

During the past 8 years, Solara Active Pharma Sciences's highest PB Ratio was 4.00. The lowest was 0.76. And the median was 1.17.

NSE:SOLARAPP's PB Ratio is ranked worse than
57.66% of 940 companies
in the Drug Manufacturers industry
Industry Median: 1.9 vs NSE:SOLARAPP: 2.26

During the past 12 months, Solara Active Pharma Sciences's average Book Value Per Share Growth Rate was -39.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -16.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -4.90% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Solara Active Pharma Sciences was 12.60% per year. The lowest was -16.30% per year. And the median was 2.75% per year.

Back to Basics: PB Ratio


Solara Active Pharma Sciences PB Ratio Historical Data

The historical data trend for Solara Active Pharma Sciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences PB Ratio Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial - - - - -

Solara Active Pharma Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 2.08 -

Competitive Comparison of Solara Active Pharma Sciences's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's PB Ratio falls into.


;
;

Solara Active Pharma Sciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Solara Active Pharma Sciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=249.20/226.235
=1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Solara Active Pharma Sciences  (NSE:SOLARAPP) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Solara Active Pharma Sciences PB Ratio Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences Business Description

Traded in Other Exchanges
Address
27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines